Atara Book Value Per Share from 2010 to 2024
| ATRA Stock | USD 0.72 0.02 2.86% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter (0.94) | Current Value (0.89) | Quarterly Volatility 6.42884046 |
Check Atara Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atara main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 M, Interest Expense of 4 M or Selling General Administrative of 51.3 M, as well as many exotic indicators such as Price To Sales Ratio of 6.02, Dividend Yield of 0.0032 or Days Sales Outstanding of 1.5 K. Atara financial statements analysis is a perfect complement when working with Atara Biotherapeutics Valuation or Volatility modules.
Atara | Book Value Per Share |
Latest Atara Biotherapeutics' Book Value Per Share Growth Pattern
Below is the plot of the Book Value Per Share of Atara Biotherapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Atara Biotherapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atara Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.93) X | 10 Years Trend |
|
Book Value Per Share |
| Timeline |
Atara Book Value Per Share Regression Statistics
| Arithmetic Mean | 4.23 | |
| Geometric Mean | 3.35 | |
| Coefficient Of Variation | 152.01 | |
| Mean Deviation | 5.05 | |
| Median | 2.99 | |
| Standard Deviation | 6.43 | |
| Sample Variance | 41.33 | |
| Range | 22.2997 | |
| R-Value | (0.04) | |
| Mean Square Error | 44.44 | |
| R-Squared | 0 | |
| Significance | 0.89 | |
| Slope | (0.06) | |
| Total Sum of Squares | 578.62 |
Atara Book Value Per Share History
Other Fundumenentals of Atara Biotherapeutics
Atara Biotherapeutics Book Value Per Share component correlations
Click cells to compare fundamentals
About Atara Biotherapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Atara Biotherapeutics income statement, its balance sheet, and the statement of cash flows. Atara Biotherapeutics investors use historical funamental indicators, such as Atara Biotherapeutics's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Atara Biotherapeutics investors may use each financial statement separately, they are all related. The changes in Atara Biotherapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Atara Biotherapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Atara Biotherapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Atara Biotherapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.94) | (0.89) | |
| Tangible Book Value Per Share | (0.94) | (0.89) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atara Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atara Biotherapeutics' short interest history, or implied volatility extrapolated from Atara Biotherapeutics options trading.
Pair Trading with Atara Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atara Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atara Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Atara Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atara Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atara Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atara Biotherapeutics to buy it.
The correlation of Atara Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atara Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atara Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atara Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Atara Biotherapeutics Correlation against competitors. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Atara Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherapeutics. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atara Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.61) | Revenue Per Share 0.081 | Quarterly Revenue Growth 13.457 | Return On Assets (0.62) | Return On Equity (20.15) |
The market value of Atara Biotherapeutics is measured differently than its book value, which is the value of Atara that is recorded on the company's balance sheet. Investors also form their own opinion of Atara Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Atara Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atara Biotherapeutics' market value can be influenced by many factors that don't directly affect Atara Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atara Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atara Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atara Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.